Human Immune Response to Ixodes Scapularis Tick Bites — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Human Immune Response to Ixodes Scapularis Tick Bites — Stella

Recruiting

Back to Tick-borne Diseases trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

National Institutes of Health Clinical Center, Bethesda, Maryland

Key details

Phase

Early testing / Safety & dosing

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Enrollment target

~60 participants

Started

February 2022

Primary completion

June 2026

Age range

18 Years – 99 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov